CA
CMD

Calton & Associates’s Cantel Medical Corporation CMD Stock Holding History

Calton & Associates’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51
Closed -$5K – 1397
2017
Q4 		$5K Buy
+51
New +$5.08K ﹤0.01% 1269

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Calton & Associates's CMD Position: Q1 2018 in Review

Calton & Associates sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 51 shares — an estimated $5K sold.

Calton & Associates first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Calton & Associates reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 51 Cantel Medical Corporation shares in Q1 2018, an estimated $5K.
  • Calton & Associates first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Cantel Medical Corporation position peaked at $5K in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.